Home
>
National Drug Code (NDC)
>
Cidofovir
Cidofovir - 67457-210-05 - (Cidofovir Anhydrous)
Drug Information of Cidofovir
| Product NDC: | 67457-210 |
| Proprietary Name: | Cidofovir |
| Non Proprietary Name: | Cidofovir Anhydrous |
| Active Ingredient(s): | 75 mg/mL & nbsp; Cidofovir Anhydrous |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cidofovir
| Product NDC: | 67457-210 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201276 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130603 |
Package Information of Cidofovir
| Package NDC: | 67457-210-05 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-210-05) > 5 mL in 1 VIAL, GLASS |
NDC Information of Cidofovir
| NDC Code | 67457-210-05 |
| Proprietary Name | Cidofovir |
| Package Description | 1 VIAL, GLASS in 1 CARTON (67457-210-05) > 5 mL in 1 VIAL, GLASS |
| Product NDC | 67457-210 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cidofovir Anhydrous |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130603 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | CIDOFOVIR |
| Strength Number | 75 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |
